GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » Valuation Rank

Feedback (LSE:FDBK) Valuation Rank


View and export this data going back to 1996. Start your Free Trial

What is Feedback Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Feedback Valuation Rank Related Terms

Thank you for viewing the detailed overview of Feedback's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Feedback (LSE:FDBK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » Valuation Rank
Comparable Companies
LSE:INHC LSE:IQAI LSE:TRLS LSE:COG AQSE:DXSP LSE:RENX GEHC VEEV SOLV ASX:PME HQY TSE:2413 RCM DOCS TXG CERT GDRX EVH PGNY PRVA
Traded in Other Exchanges
N/A
Address
3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Website
https://www.fbkmed.com
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. The company also entered into a joint venture for future clinical application of its products on patients with kidney stones and it has a medical imaging segment.